European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
- PMID: 32101604
- DOI: 10.1093/eurheartj/ehaa010
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Abstract
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially lifesaving treatments for a number of cardiac conditions but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased health care costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well-recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, antibacterial envelopes, prolonged antibiotics post-implantation, and others. When compared with previous guidelines or consensus statements, the present consensus document gives guidance on the use of novel device alternatives, novel oral anticoagulants, antibacterial envelopes, prolonged antibiotics post-implantation, as well as definitions on minimum quality requirements for centres and operators and volumes. The recognition that an international consensus document focused on management of CIED infections is lacking, the dissemination of results from new important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a Novel 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections.
Keywords: Defibrillator; Device; Extraction; Leads; Pacemaker; Infection.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).Eur J Cardiothorac Surg. 2020 Jan 1;57(1):e1-e31. doi: 10.1093/ejcts/ezz296. Eur J Cardiothorac Surg. 2020. PMID: 31724720
-
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).Europace. 2020 Apr 1;22(4):515-549. doi: 10.1093/europace/euz246. Europace. 2020. PMID: 31702000 Free PMC article.
-
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS).JACC Clin Electrophysiol. 2021 Nov;7(11):1437-1472. doi: 10.1016/j.jacep.2021.07.009. Epub 2021 Jul 29. JACC Clin Electrophysiol. 2021. PMID: 34794667
-
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).Europace. 2019 Feb 1;21(2):192-193. doi: 10.1093/europace/euy174. Europace. 2019. PMID: 30052888 Review.
-
European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS).Europace. 2019 Jan 1;21(1):7-8. doi: 10.1093/europace/euy110. Europace. 2019. PMID: 29905786 Review. No abstract available.
Cited by
-
Complicated Pocket Infection in Patients Undergoing Lead Extraction: Characteristics and Outcomes.J Clin Med. 2023 Jun 29;12(13):4397. doi: 10.3390/jcm12134397. J Clin Med. 2023. PMID: 37445433 Free PMC article.
-
Prevalence of cardiac implantable electronic device infections in Germany in 2015.Sci Rep. 2024 Dec 16;14(1):30513. doi: 10.1038/s41598-024-82622-1. Sci Rep. 2024. PMID: 39681674 Free PMC article.
-
Healthcare-Associated Infective Endocarditis-Surgical Perspectives.J Clin Med. 2022 Aug 24;11(17):4957. doi: 10.3390/jcm11174957. J Clin Med. 2022. PMID: 36078887 Free PMC article. Review.
-
Long-term results of conservative treatment of pacemaker pocket site infections.Postepy Kardiol Interwencyjnej. 2022 Sep;18(3):290-295. doi: 10.5114/aic.2022.120372. Epub 2022 Nov 2. Postepy Kardiol Interwencyjnej. 2022. PMID: 36751293 Free PMC article.
-
Risk factors associated with higher mortality in patients with cardiac implantable electronic device infection.J Cardiovasc Electrophysiol. 2023 Mar;34(3):738-747. doi: 10.1111/jce.15817. Epub 2023 Jan 19. J Cardiovasc Electrophysiol. 2023. PMID: 36640427 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical